SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,123.83 -125.56
( -0.17%)

Global Indices

Nasdaq

52,230.09 -658.89
(-1.25%)

Dow Jones

7,644.13 -40.30
(-0.52%)

Hang Seng

62,584.98 -322.86
(-0.51%)

Nikkei 225

10,670.63 -54.40
(-0.51%)

Forex

USD-INR

94.61 0.10
(0.11%)

EUR-INR

106.18 0.08
(0.07%)

GBP-INR

126.70 0.19
(0.15%)

JPY-INR

0.60 0.00
(0.70%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Asston Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

544445

INE0SJX01015

60.9571459

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

36.25

141.77

EPS(TTM)

Face Value()

Div & Yield %

3.58

Back

CEAT consolidated net profit declines 39.78% in the September 2026 quarter

Oct 15,2026

Net profit of CEAT declined 39.78% to Rs 112.00 crore in the quarter ended September 2026 as against Rs 186.00 crore during the previous quarter ended September 2025. Sales rose 26.21% to Rs 4762.00 crore in the quarter ended September 2026 as against Rs 3773.00 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	4762.00	3773.00	26
OPM %	9.60	13.33	-
PBDT	375.00	420.00	-11
PBT	182.00	246.00	-26
NP	112.00	186.00	-40

73,123.83 -125.56 ( -0.17%)

52,230.09 -658.89 (-1.25%)

7,644.13 -40.30 (-0.52%)

62,584.98 -322.86 (-0.51%)

10,670.63 -54.40 (-0.51%)

94.61 0.10 (0.11%)

106.18 0.08 (0.07%)

126.70 0.19 (0.15%)

0.60 0.00 (0.70%)